 |
|
(sir-OH-lih-mus)
| | A drug used to prevent the rejection of organ and bone marrow transplants by the body. Sirolimus is an antibiotic that blocks a protein involved in cell division and inhibits the growth and function of certain T cells of the immune system that are involved in the body's rejection of foreign tissues and organs. It is a type of immunosuppressant and a type of serine/threonine kinase inhibitor. Sirolimus was previously called rapamycin. Also called Rapamune. |
| Previous Definitions: | single nucleotide polymorphism, single-photon emission computed tomography, Singulair, siplizumab, Sipuleucel-T | | Next Definitions: | SIRS, SJG-136, Sjögren syndrome, SK&F106615, skeletal |
|
|
